US FDA approves Jazz Pharmaceuticals’ Modeyso to treat recurrent H3 K27M-mutant diffuse midline glioma: Dublin Friday, August 8, 2025, 11:00 Hrs [IST] Jazz Pharmaceuticals plc, ...

A police presence was reported on Needham Street in Modesto Wednesday afternoon. Video Above | 5 a.m. Headlines from KCRA ...

Three young friends of Maddie O’Hare Schmidt held a lemonade stand on Thursday to raise funds for Magic for Maddie, a ...

A man is dead after being involved in a crash with a vehicle that went into part of the California Aqueduct on I-5 in Modesto ...

There are eight Modesto locations of Dollar Tree, not including any under construction: 1620 Standiford Ave., 2425 McHenry ...

Central Valley Snowie, a family-owned business in Modesto, is asking for community help after a hit-and-run destroyed their ...

Stanislaus County supervisors are getting a pay increase of 11% over three years because of a policy that gives them the same ...

Class-wide label change for opioids; positive results for oral GLP-1; migraine prevention therapy approved for children; FDA removes restriction on Ixchiq for older adults; Modeyso approved for rare ...

A Salinas teen has triumphed over adversity, achieving remarkable success after waking up from a coma following a car crash ...

Get With The Guidelines is an in-hospital program designed to improve care by promoting consistent adherence to the latest scientific treatment guidelines.

Temperatures continue to climb above normal as we head into the weekend.

Modeyso is the first drug to treat patients with diffuse midline glioma with an H3 K27M mutation, an ultra-rare and aggressive brain tumor.